Substituted imidazopyridazines
AssigneeBayer Intellectual Property GmbH
InventorsKnut Eis, Florian Puehler, Ludwig Zorn, Arne Scholz, Philip Lienau, Mark Jean Gnoth, Ulf Bömer, Judith Günther
Life of this patent
Estimating the term…
Loading patent…
AssigneeBayer Intellectual Property GmbH
InventorsKnut Eis, Florian Puehler, Ludwig Zorn, Arne Scholz, Philip Lienau, Mark Jean Gnoth, Ulf Bömer, Judith Günther
Estimating the term…
The present invention relates to substituted imidazopyridazine compounds of general formula (I): in which A, Q, R1, R3, R4 and n are as defined in the claims, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.
A compound of general formula (I):
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.